525 related articles for article (PubMed ID: 25896770)
1. Overexpression of BDNF and Full-Length TrkB Receptor Ameliorate Striatal Neural Survival in Huntington's Disease.
Silva A; Naia L; Dominguez A; Ribeiro M; Rodrigues J; Vieira OV; Lessmann V; Rego AC
Neurodegener Dis; 2015; 15(4):207-18. PubMed ID: 25896770
[TBL] [Abstract][Full Text] [Related]
2. Imbalance of p75(NTR)/TrkB protein expression in Huntington's disease: implication for neuroprotective therapies.
Brito V; Puigdellívol M; Giralt A; del Toro D; Alberch J; Ginés S
Cell Death Dis; 2013 Apr; 4(4):e595. PubMed ID: 23598407
[TBL] [Abstract][Full Text] [Related]
3. Mutant Huntingtin alters retrograde transport of TrkB receptors in striatal dendrites.
Liot G; Zala D; Pla P; Mottet G; Piel M; Saudou F
J Neurosci; 2013 Apr; 33(15):6298-309. PubMed ID: 23575829
[TBL] [Abstract][Full Text] [Related]
4. Selective reduction of striatal mature BDNF without induction of proBDNF in the zQ175 mouse model of Huntington's disease.
Ma Q; Yang J; Li T; Milner TA; Hempstead BL
Neurobiol Dis; 2015 Oct; 82():466-477. PubMed ID: 26282324
[TBL] [Abstract][Full Text] [Related]
5. Early Downregulation of p75
Suelves N; Miguez A; López-Benito S; Barriga GG; Giralt A; Alvarez-Periel E; Arévalo JC; Alberch J; Ginés S; Brito V
Mol Neurobiol; 2019 Feb; 56(2):935-953. PubMed ID: 29804232
[TBL] [Abstract][Full Text] [Related]
6. Potential role of TrkB agonist in neuronal survival by promoting CREB/BDNF and PI3K/Akt signaling in vitro and in vivo model of 3-nitropropionic acid (3-NP)-induced neuronal death.
Ahmed S; Kwatra M; Gawali B; Panda SR; Naidu VGM
Apoptosis; 2021 Feb; 26(1-2):52-70. PubMed ID: 33226552
[TBL] [Abstract][Full Text] [Related]
7. Reduced expression of the TrkB receptor in Huntington's disease mouse models and in human brain.
Ginés S; Bosch M; Marco S; Gavaldà N; Díaz-Hernández M; Lucas JJ; Canals JM; Alberch J
Eur J Neurosci; 2006 Feb; 23(3):649-58. PubMed ID: 16487146
[TBL] [Abstract][Full Text] [Related]
8. Impaired TrkB-mediated ERK1/2 activation in huntington disease knock-in striatal cells involves reduced p52/p46 Shc expression.
Ginés S; Paoletti P; Alberch J
J Biol Chem; 2010 Jul; 285(28):21537-48. PubMed ID: 20442398
[TBL] [Abstract][Full Text] [Related]
9. TRiC subunits enhance BDNF axonal transport and rescue striatal atrophy in Huntington's disease.
Zhao X; Chen XQ; Han E; Hu Y; Paik P; Ding Z; Overman J; Lau AL; Shahmoradian SH; Chiu W; Thompson LM; Wu C; Mobley WC
Proc Natl Acad Sci U S A; 2016 Sep; 113(38):E5655-64. PubMed ID: 27601642
[TBL] [Abstract][Full Text] [Related]
10. Region-specific pro-survival signaling and global neuronal protection by wild-type Huntingtin.
Buren C; Wang L; Smith-Dijak A; Raymond LA
J Huntingtons Dis; 2014; 3(4):365-76. PubMed ID: 25575958
[TBL] [Abstract][Full Text] [Related]
11. The p75 neurotrophin receptor augments survival signaling in the striatum of pre-symptomatic Q175(WT/HD) mice.
Wehner AB; Milen AM; Albin RL; Pierchala BA
Neuroscience; 2016 Jun; 324():297-306. PubMed ID: 26947127
[TBL] [Abstract][Full Text] [Related]
12. A monoclonal antibody TrkB receptor agonist as a potential therapeutic for Huntington's disease.
Todd D; Gowers I; Dowler SJ; Wall MD; McAllister G; Fischer DF; Dijkstra S; Fratantoni SA; van de Bospoort R; Veenman-Koepke J; Flynn G; Arjomand J; Dominguez C; Munoz-Sanjuan I; Wityak J; Bard JA
PLoS One; 2014; 9(2):e87923. PubMed ID: 24503862
[TBL] [Abstract][Full Text] [Related]
13. 7,8-dihydroxyflavone ameliorates cognitive and motor deficits in a Huntington's disease mouse model through specific activation of the PLCγ1 pathway.
García-Díaz Barriga G; Giralt A; Anglada-Huguet M; Gaja-Capdevila N; Orlandi JG; Soriano J; Canals JM; Alberch J
Hum Mol Genet; 2017 Aug; 26(16):3144-3160. PubMed ID: 28541476
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of TrkB phosphorylation and proBDNF protein in adenylyl cyclase 1 and 8 knockout mice in a model of fetal alcohol spectrum disorder.
Susick LL; Chrumka AC; Hool SM; Conti AC
Alcohol; 2016 Mar; 51():25-35. PubMed ID: 26992697
[TBL] [Abstract][Full Text] [Related]
15. SORLA-mediated trafficking of TrkB enhances the response of neurons to BDNF.
Rohe M; Hartl D; Fjorback AN; Klose J; Willnow TE
PLoS One; 2013; 8(8):e72164. PubMed ID: 23977241
[TBL] [Abstract][Full Text] [Related]
16. BDNF overexpression in the forebrain rescues Huntington's disease phenotypes in YAC128 mice.
Xie Y; Hayden MR; Xu B
J Neurosci; 2010 Nov; 30(44):14708-18. PubMed ID: 21048129
[TBL] [Abstract][Full Text] [Related]
17. A small molecule TrkB ligand reduces motor impairment and neuropathology in R6/2 and BACHD mouse models of Huntington's disease.
Simmons DA; Belichenko NP; Yang T; Condon C; Monbureau M; Shamloo M; Jing D; Massa SM; Longo FM
J Neurosci; 2013 Nov; 33(48):18712-27. PubMed ID: 24285878
[TBL] [Abstract][Full Text] [Related]
18. Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4/5 prevent the death of striatal projection neurons in a rodent model of Huntington's disease.
Pérez-Navarro E; Canudas AM; Akerund P; Alberch J; Arenas E
J Neurochem; 2000 Nov; 75(5):2190-9. PubMed ID: 11183872
[TBL] [Abstract][Full Text] [Related]
19. Impaired TrkB Signaling Underlies Reduced BDNF-Mediated Trophic Support of Striatal Neurons in the R6/2 Mouse Model of Huntington's Disease.
Nguyen KQ; Rymar VV; Sadikot AF
Front Cell Neurosci; 2016; 10():37. PubMed ID: 27013968
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of long noncoding antisense RNA brain-derived neurotrophic factor attenuates hypoxia/reoxygenation-induced nerve cell apoptosis through the BDNF-TrkB-PI3K/Akt signaling pathway.
Zhong JB; Li X; Zhong SM; Liu JD; Chen CB; Wu XY
Neuroreport; 2017 Sep; 28(14):910-916. PubMed ID: 28777258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
